Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-20-002208
Filing Date
2020-01-31
Accepted
2020-01-31 06:03:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 SCHEDULE 13G sc13g0120a3eddleman_repligen.htm SC 13G/A 60478
  Complete submission text file 0001213900-20-002208.txt   61778
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Subject) CIK: 0000730272 (see all company filings)

EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-38071 | Film No.: 20563191
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 110 W. GEORGE BURNS ROAD SUITE D-4018 LOS ANGELES CA 90048
Business Address
EDDLEMAN ROY T (Filed by) CIK: 0001270264 (see all company filings)

Type: SC 13G/A